Northern Trust’s ENDRA Life Sciences NDRA Stock Holding History

Northern Trust’s Portfolio NDRA Stock Details NDRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2	Closed	-$19K	–	4690
2022 Q3	$19K	Hold	2	–	–	﹤0.01%	4555
2022 Q2	$15K	Hold	2	–	–	﹤0.01%	4656
2022 Q1	$25K	Hold	2	–	–	﹤0.01%	4646
2021 Q4	$44K	Hold	2	–	–	﹤0.01%	4612
2021 Q3	$110K	Hold	2	–	–	﹤0.01%	4373
2021 Q2	$138K	Hold	2	–	–	﹤0.01%	4278
2021 Q1	$165K	Buy	2 +1	+100%	+$74.9K	﹤0.01%	4162
2020 Q4	$22K	Hold	1	–	–	﹤0.01%	4315
2020 Q3	$21K	Buy	+1	New	+$30.8K	﹤0.01%	4207
2020 Q2	–	Hold	0	–	–	–	4195
2020 Q1	–	Hold	0	–	–	–	4144
2019 Q4	–	Hold	0	–	–	–	4122
2019 Q3	–	Hold	0	–	–	–	4167
2019 Q2	–	Hold	0	–	–	–	4143
2019 Q1	–	Hold	0	–	–	–	4107
2018 Q4	–	Hold	0	–	–	–	4145

Other funds holding NDRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

WAM

Worth Asset Management Dallas, Texas $313M AUM 37.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Northern Trust's NDRA Position: Q4 2022 in Review

Northern Trust sold out of ENDRA Life Sciences (NDRA) in Q4 2022, closing a stake of 2 shares — an estimated $19K sold.

Northern Trust first reported a position in NDRA in Q3 2020 and held it in 9 quarters. The position peaked at $165K in Q1 2021. 8 funds tracked by Wall St. Rank hold NDRA as of Q4 2022.

Northern Trust reported no remaining ENDRA Life Sciences position as of Q4 2022 after selling out during the quarter.
Northern Trust sold 2 ENDRA Life Sciences shares in Q4 2022, an estimated $19K.
Northern Trust first reported a position in ENDRA Life Sciences in Q3 2020 and held it in 9 quarters.
Northern Trust's ENDRA Life Sciences position peaked at $165K in Q1 2021.
8 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q4 2022.

Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.